The Israeli Society for HealthTech's Program in Medical Innovation and Advanced Technologies

​

Next Cohort Starts October 2026  
 

Program Team: Prof. Noam Shomron, Academic Director; Dr. Hedva Voliovitch, MD, PhD, MBA; Prof. Noah Liel-Cohen, MD; Dr. Neomi Siegel, MD; Dan Shwarzman
Objective: Enabling physicians to take on leadership roles within the Israeli healthtech ecosystem

About the Program: There is an increasing need for physicians equipped to evaluate, develop, and implement innovative technologies within health systems and industry.

This one-year program, offered together with the CME framework at Tel Aviv University’s Faculty of Medical & Health Sciences, is designed for board-certified physicians who want to gain structured training, hands-on experience, and the leadership skills required to advance medical innovation - alongside their ongoing clinical practice.

The program enables specialist physicians from all disciplines to gain focused knowledge and engage directly with leading technology companies, startups, and VCs.

Graduates will be well positioned to contribute to and lead medical innovation in both healthcare organizations and industry.

The program begins with a two-week introductory course that familiarizes the participants with key topics such as regulation, entrepreneurship, and ethics; medical devices, digital health, and pharmaceutics. 
It is followed by two five-month rotations at healthtech companies where participants gain hands-on exposure to major technological and managerial aspects of healthtech business and actively participate in ongoing projects. 

Each participant is guided by a dedicated physician mentor throughout the year.

Importantly, clinical work is maintained during the program, and the program aims to empower participants to continue incorporating healthtech into their clinical expertise, fostering national efforts to advance healthtech adoption and drive innovation.

The Israeli Society for HealthTech also runs and develops additional training programs for key stakeholders in the future of healthcare.